Muscat – These initiatives aim to support the local manufacturing industry and enhance the country’s pharmaceutical security.
Key Agreements:
- Localisation of intravenous solutions and dialysis solutions with Dhofar Pharmaceutical Factory.
- Localisation of various medications and injectable medicines with Felix Pharmaceutical Industries.
- Localisation of vital medications with Opal Bio Pharma Factory.
- Localisation of intravenous solutions with Izz Pharmaceutical Industries.
- Localisation of specialized medications for the treatment of genetic diseases, metabolic disorders, and blood diseases with Menagen Pharmaceutical Industries.
- Localization of medical supplies products with a health supplies factory.
Through these strategic agreements, the Ministry aims to achieve several critical objectives.
These include the following:
• Attracting investments and localizing industries.
• Strengthening local content in the healthcare sector.
• Ensuring pharmaceutical security.
• Increasing the contribution of the industrial sector to the national GDP.
Read More
- His Majesty Sultan Haitham returns home after state visits to China, Brunei
- Oman’s digital economy contributes 9% to GDP as investments reach RO 1.3 billion in 2025
- Muscat Municipality announces traffic diversion on Al Khuwair service road from November 4
- Oman clarifies expat recruitment rules after agency talks
- Oman police arrest two over vehicle theft, number plate tampering and resisting officers in Seeb





